The Small Interfering RNA (siRNA) Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Small Interfering RNA (siRNA) Therapeutics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Small Interfering RNA (siRNA) Therapeutics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Liposome Based Systemic Therapy segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Small Interfering RNA (siRNA) Therapeutics include GE, Horizon Discovery, Thermo Scientific, OPKO Health, and AInylam Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Small Interfering RNA (siRNA) Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Liposome Based Systemic Therapy
- Nanoparticle Based Systemic Therapy
- Other
Market segment by Application, can be divided into
- Hospital
- Research Institutions
- Pharmaceutical and Biotechnology Companies
- Academic Institutions
- Other
Market segment by players, this report covers
- GE
- Horizon Discovery
- Thermo Scientific
- OPKO Health
- AInylam Pharmaceuticals
- Arrowhead Research
- Sanofi Genzyme
- Genecon Biotechnologies
- Arbutus Biopharma
- Silent Therapeutics
- Sylentis
Market segment by regions, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Small Interfering RNA (siRNA) Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Small Interfering RNA (siRNA) Therapeutics, with revenue, gross margin and global market share of Small Interfering RNA (siRNA) Therapeutics from 2019 to 2022.
Chapter 3, the Small Interfering RNA (siRNA) Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Small Interfering RNA (siRNA) Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Small Interfering RNA (siRNA) Therapeutics research findings and conclusion, appendix and data source.
Global Small Interfering RNA (siRNA) Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Small Interfering RNA (siRNA) Therapeutics
1.2 Classification of Small Interfering RNA (siRNA) Therapeutics by Type
1.2.1 Overview: Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Type in 2021
1.2.3 Liposome Based Systemic Therapy
1.2.4 Nanoparticle Based Systemic Therapy
1.2.5 Other
1.3 Global Small Interfering RNA (siRNA) Therapeutics Market by Application
1.3.1 Overview: Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Research Institutions
1.3.4 Pharmaceutical and Biotechnology Companies
1.3.5 Academic Institutions
1.3.6 Other
1.4 Global Small Interfering RNA (siRNA) Therapeutics Market Size & Forecast
1.5 Global Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast by Region
1.5.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Region, (2017-2022)
1.5.3 North America Small Interfering RNA (siRNA) Therapeutics Market Size and Prospect (2017-2028)
1.5.4 Europe Small Interfering RNA (siRNA) Therapeutics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size and Prospect (2017-2028)
1.5.6 South America Small Interfering RNA (siRNA) Therapeutics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Small Interfering RNA (siRNA) Therapeutics Market Drivers
1.6.2 Small Interfering RNA (siRNA) Therapeutics Market Restraints
1.6.3 Small Interfering RNA (siRNA) Therapeutics Trends Analysis
2 Company Profiles
2.1 GE
2.1.1 GE Details
2.1.2 GE Major Business
2.1.3 GE Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.1.4 GE Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 GE Recent Developments and Future Plans
2.2 Horizon Discovery
2.2.1 Horizon Discovery Details
2.2.2 Horizon Discovery Major Business
2.2.3 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.2.4 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Horizon Discovery Recent Developments and Future Plans
2.3 Thermo Scientific
2.3.1 Thermo Scientific Details
2.3.2 Thermo Scientific Major Business
2.3.3 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.3.4 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Thermo Scientific Recent Developments and Future Plans
2.4 OPKO Health
2.4.1 OPKO Health Details
2.4.2 OPKO Health Major Business
2.4.3 OPKO Health Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.4.4 OPKO Health Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 OPKO Health Recent Developments and Future Plans
2.5 AInylam Pharmaceuticals
2.5.1 AInylam Pharmaceuticals Details
2.5.2 AInylam Pharmaceuticals Major Business
2.5.3 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.5.4 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 AInylam Pharmaceuticals Recent Developments and Future Plans
2.6 Arrowhead Research
2.6.1 Arrowhead Research Details
2.6.2 Arrowhead Research Major Business
2.6.3 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.6.4 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Arrowhead Research Recent Developments and Future Plans
2.7 Sanofi Genzyme
2.7.1 Sanofi Genzyme Details
2.7.2 Sanofi Genzyme Major Business
2.7.3 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.7.4 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Sanofi Genzyme Recent Developments and Future Plans
2.8 Genecon Biotechnologies
2.8.1 Genecon Biotechnologies Details
2.8.2 Genecon Biotechnologies Major Business
2.8.3 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.8.4 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Genecon Biotechnologies Recent Developments and Future Plans
2.9 Arbutus Biopharma
2.9.1 Arbutus Biopharma Details
2.9.2 Arbutus Biopharma Major Business
2.9.3 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.9.4 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Arbutus Biopharma Recent Developments and Future Plans
2.10 Silent Therapeutics
2.10.1 Silent Therapeutics Details
2.10.2 Silent Therapeutics Major Business
2.10.3 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.10.4 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Silent Therapeutics Recent Developments and Future Plans
2.11 Sylentis
2.11.1 Sylentis Details
2.11.2 Sylentis Major Business
2.11.3 Sylentis Small Interfering RNA (siRNA) Therapeutics Product and Solutions
2.11.4 Sylentis Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Sylentis Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Small Interfering RNA (siRNA) Therapeutics Players Market Share in 2021
3.2.2 Top 10 Small Interfering RNA (siRNA) Therapeutics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Small Interfering RNA (siRNA) Therapeutics Players Head Office, Products and Services Provided
3.4 Small Interfering RNA (siRNA) Therapeutics Mergers & Acquisitions
3.5 Small Interfering RNA (siRNA) Therapeutics New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue and Market Share by Type (2017-2022)
4.2 Global Small Interfering RNA (siRNA) Therapeutics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Application (2017-2022)
5.2 Global Small Interfering RNA (siRNA) Therapeutics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2017-2028)
6.2 North America Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2017-2028)
6.3 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country
6.3.1 North America Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2017-2028)
6.3.2 United States Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
6.3.3 Canada Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
6.3.4 Mexico Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2017-2028)
7.2 Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2017-2028)
7.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country
7.3.1 Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2017-2028)
7.3.2 Germany Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
7.3.3 France Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
7.3.5 Russia Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
7.3.6 Italy Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2017-2028)
8.2 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2017-2028)
8.3 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Region
8.3.1 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Region (2017-2028)
8.3.2 China Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
8.3.3 Japan Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
8.3.4 South Korea Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
8.3.5 India Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
8.3.7 Australia Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2017-2028)
9.2 South America Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2017-2028)
9.3 South America Small Interfering RNA (siRNA) Therapeutics Market Size by Country
9.3.1 South America Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2017-2028)
9.3.2 Brazil Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
9.3.3 Argentina Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2017-2028)
10.2 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2017-2028)
10.3 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Country
10.3.1 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2017-2028)
10.3.2 Turkey Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
10.3.4 UAE Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Small Interfering RNA (siRNA) Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Small Interfering RNA (siRNA) Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Small Interfering RNA (siRNA) Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Region (2023-2028)
Table 6. GE Corporate Information, Head Office, and Major Competitors
Table 7. GE Major Business
Table 8. GE Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 9. GE Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Horizon Discovery Corporate Information, Head Office, and Major Competitors
Table 11. Horizon Discovery Major Business
Table 12. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 13. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Thermo Scientific Corporate Information, Head Office, and Major Competitors
Table 15. Thermo Scientific Major Business
Table 16. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 17. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. OPKO Health Corporate Information, Head Office, and Major Competitors
Table 19. OPKO Health Major Business
Table 20. OPKO Health Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 21. OPKO Health Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. AInylam Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. AInylam Pharmaceuticals Major Business
Table 24. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 25. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Arrowhead Research Corporate Information, Head Office, and Major Competitors
Table 27. Arrowhead Research Major Business
Table 28. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 29. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Sanofi Genzyme Corporate Information, Head Office, and Major Competitors
Table 31. Sanofi Genzyme Major Business
Table 32. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 33. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Genecon Biotechnologies Corporate Information, Head Office, and Major Competitors
Table 35. Genecon Biotechnologies Major Business
Table 36. Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 37. Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Arbutus Biopharma Corporate Information, Head Office, and Major Competitors
Table 39. Arbutus Biopharma Major Business
Table 40. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 41. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Silent Therapeutics Corporate Information, Head Office, and Major Competitors
Table 43. Silent Therapeutics Major Business
Table 44. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 45. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Sylentis Corporate Information, Head Office, and Major Competitors
Table 47. Sylentis Major Business
Table 48. Sylentis Small Interfering RNA (siRNA) Therapeutics Product and Solutions
Table 49. Sylentis Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Global Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 51. Global Small Interfering RNA (siRNA) Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 52. Breakdown of Small Interfering RNA (siRNA) Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Small Interfering RNA (siRNA) Therapeutics Players Head Office, Products and Services Provided
Table 54. Small Interfering RNA (siRNA) Therapeutics Mergers & Acquisitions in the Past Five Years
Table 55. Small Interfering RNA (siRNA) Therapeutics New Entrants and Expansion Plans
Table 56. Global Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million) by Type (2017-2022)
Table 57. Global Small Interfering RNA (siRNA) Therapeutics Revenue Share by Type (2017-2022)
Table 58. Global Small Interfering RNA (siRNA) Therapeutics Revenue Forecast by Type (2023-2028)
Table 59. Global Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2017-2022)
Table 60. Global Small Interfering RNA (siRNA) Therapeutics Revenue Forecast by Application (2023-2028)
Table 61. North America Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 62. North America Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 63. North America Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 64. North America Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 65. North America Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 66. North America Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 67. Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 68. Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 69. Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 70. Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 71. Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 72. Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 73. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 74. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 75. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 76. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 77. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Region (2017-2022) & (USD Million)
Table 78. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Region (2023-2028) & (USD Million)
Table 79. South America Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 80. South America Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 81. South America Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 82. South America Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 83. South America Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 84. South America Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 85. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 86. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 87. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 88. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 89. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 90. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Small Interfering RNA (siRNA) Therapeutics Picture
Figure 2. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Type in 2021
Figure 3. Liposome Based Systemic Therapy
Figure 4. Nanoparticle Based Systemic Therapy
Figure 5. Other
Figure 6. Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Application in 2021
Figure 7. Hospital Picture
Figure 8. Research Institutions Picture
Figure 9. Pharmaceutical and Biotechnology Companies Picture
Figure 10. Academic Institutions Picture
Figure 11. Other Picture
Figure 12. Global Small Interfering RNA (siRNA) Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Small Interfering RNA (siRNA) Therapeutics Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Region (2017-2028)
Figure 15. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Region in 2021
Figure 16. North America Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Small Interfering RNA (siRNA) Therapeutics Market Drivers
Figure 22. Small Interfering RNA (siRNA) Therapeutics Market Restraints
Figure 23. Small Interfering RNA (siRNA) Therapeutics Market Trends
Figure 24. GE Recent Developments and Future Plans
Figure 25. Horizon Discovery Recent Developments and Future Plans
Figure 26. Thermo Scientific Recent Developments and Future Plans
Figure 27. OPKO Health Recent Developments and Future Plans
Figure 28. AInylam Pharmaceuticals Recent Developments and Future Plans
Figure 29. Arrowhead Research Recent Developments and Future Plans
Figure 30. Sanofi Genzyme Recent Developments and Future Plans
Figure 31. Genecon Biotechnologies Recent Developments and Future Plans
Figure 32. Arbutus Biopharma Recent Developments and Future Plans
Figure 33. Silent Therapeutics Recent Developments and Future Plans
Figure 34. Sylentis Recent Developments and Future Plans
Figure 35. Global Small Interfering RNA (siRNA) Therapeutics Revenue Share by Players in 2021
Figure 36. Small Interfering RNA (siRNA) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players Small Interfering RNA (siRNA) Therapeutics Revenue Market Share in 2021
Figure 38. Global Top 10 Players Small Interfering RNA (siRNA) Therapeutics Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global Small Interfering RNA (siRNA) Therapeutics Revenue Share by Type in 2021
Figure 41. Global Small Interfering RNA (siRNA) Therapeutics Market Share Forecast by Type (2023-2028)
Figure 42. Global Small Interfering RNA (siRNA) Therapeutics Revenue Share by Application in 2021
Figure 43. Global Small Interfering RNA (siRNA) Therapeutics Market Share Forecast by Application (2023-2028)
Figure 44. North America Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2017-2028)
Figure 45. North America Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application (2017-2028)
Figure 46. North America Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Country (2017-2028)
Figure 47. United States Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2017-2028)
Figure 51. Europe Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application (2017-2028)
Figure 52. Europe Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Country (2017-2028)
Figure 53. Germany Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Region (2017-2028)
Figure 61. China Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2017-2028)
Figure 68. South America Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application (2017-2028)
Figure 69. South America Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Country (2017-2028)
Figure 75. Turkey Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
Published: 11-Jan-2024 Price: US 3350 Onwards Pages: 118
The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029.
Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the glo......
Global Non-imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 95
The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 90
The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
Global PCR Equipment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 77
The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030.
PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers:
Advancements in Research and Diagnost......
Global Disposable Sterile Syringes and Needles Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 109
The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030.
North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Disposable Sterile Syringes and N......
Global Orthopaedic Power Tools Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030.
North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
Global Cerebrospinal Fluid Management Devices Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
Global CAD & CAM Milling Burs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
Global Artificial Teeth Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 98
The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
